The "Global Nucleic Acid Testing/NAT Market Country Forecasts and Supplier Shares 2017-2021: Global Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to ResearchAndMarkets.com's offering.
The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Report Highlights
- Business and technological trends in seven major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies and products
- Specific product and business opportunities for instrument and consumable suppliers
Companies Mentioned
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- Biokit
- bioMerieux
- Biotest
- CellMark Forensics/LabCorpCepheid
- Cepheid
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Takara Bio
- Tecan Group
- Thermo Fisher
Key Topics Covered:
I. Introduction
II. Major Product Development Opportunities
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
V. Potential Market Entry Barriers and Risks
VI. Worldwide Market and Technology Review
VII. Worldwide Market Overview
VIII. France Molecular Diagnostics Market
IX. Germany Molecular Diagnostics Market
X. Italy Molecular Diagnostics Market
XI. Japan Molecular Diagnostics Market
XII. Spain Molecular Diagnostics Market
XIII. U.K. Molecular Diagnostics Market
XIV. U.S.A. Molecular Diagnostics Market
XV. Competitive Assessments
XVI. Appendix: Major Universities and Research Centers
For more information about this report visit https://www.researchandmarkets.com/research/w9n3zj/global_nucleic?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20180129005671/en/